A Novel Integrated Perioperative Cardiovascular Risk Score (PERFORM-CV) in Non-Cardiac Surgical Patients
Journal of Cardiovascular Development and Disease · 10.04.2026 · 13 (4) · 165
DOI: 10.3390/jcdd13040165 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cardiovascular Development and Disease, online erschienen am 10.04.2026. Verfasst von Andreea Boghean und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Pharmacy, Research Centre in the Medical-Pharmaceutical Field, "Dunarea de Jos" University of Galati, 800008 Galati, Romania. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: “Dunarea de Jos” University of Galati.
Abstract (Originalsprache)
Background
Perioperative cardiovascular risk assessment remains challenging in non-cardiac surgery, particularly in older patients and those with multiple comorbidities. Traditional models rely largely on clinical history and may not fully reflect current cardiovascular functional status. This study aimed to derive and assess the apparent performance of a new composite score, PERFORM-CV, integrating clinical, laboratory, and echocardiographic data.
Methods
We conducted a prospective two-center cohort study including 503 non-cardiac surgical patients with cardiovascular comorbidity. The Revised Cardiac Risk Index (Lee/RCRI) and the AUB-HAS2 index were calculated according to their original published definitions as raw point totals ranging from 0 to 6; without additional normalization. The PERFORM-CV score was derived from univariable and multivariable analyses, with continuous predictors dichotomized using ROC-derived thresholds.
Results
Emergency admission, chronic heart failure, and elevated serum creatinine remained independently associated with in-hospital mortality. Lower left ventricular ejection fraction, lower mitral annular plane systolic excursion (MAPSE), lower hemoglobin, and atrial fibrillation also contributed to the final composite score. ROC analysis showed good discrimination for PERFORM-CV (AUC 0.852; 95% CI 0.806–0.897; p < 0.001), comparable to Lee/RCRI (AUC 0.860; 95% CI 0.818–0.901; p < 0.001) and higher than AUB-HAS2 (AUC 0.779; 95% CI 0.731–0.826; p < 0.001).
Conclusions
PERFORM-CV showed good apparent discrimination in the derivation cohort and may complement established bedside risk tools by incorporating echocardiographic and laboratory data. The ROC-derived thresholds should be interpreted as data-driven derivation cut-offs; resampling-based internal validation and external validation are required before broader clinical use.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine and Pharmacy, Research Centre in the Medical-Pharmaceutical Field, "Dunarea de Jos" University of Galati, 800008 Galati, Romania.
- Cardiology Department, "Dr. Aristide Serfioti" Emergency Military Hospital, 800150 Galati, Romania.
- Radiotherapy Department, "Sf. Apostol Andrei" County Emergency Clinical Hospital, 800578 Galati, Romania.
ORCID-Profile: Andreea Boghean, Cristian Gutu, Dorel Firescu
Förderung
- “Dunarea de Jos” University of Galati
Zitieren
APA
Boghean, A., Gutu, C., Rebegea, L. F., & Firescu, D. (2026). A Novel Integrated Perioperative Cardiovascular Risk Score (PERFORM-CV) in Non-Cardiac Surgical Patients. Journal of Cardiovascular Development and Disease, 13(4), 165. https://doi.org/10.3390/jcdd13040165
Vancouver
Boghean A, Gutu C, Rebegea LF, Firescu D. A Novel Integrated Perioperative Cardiovascular Risk Score (PERFORM-CV) in Non-Cardiac Surgical Patients. Journal of Cardiovascular Development and Disease. 2026;13(4):165. doi:10.3390/jcdd13040165
BibTeX
@article{Boghean2026,
author = {Boghean, Andreea and Gutu, Cristian and Rebegea, Laura Florentina and Firescu, Dorel},
title = {A Novel Integrated Perioperative Cardiovascular Risk Score (PERFORM-CV) in Non-Cardiac Surgical Patients},
journal = {Journal of Cardiovascular Development and Disease},
year = {2026},
volume = {13},
number = {4},
pages = {165},
doi = {10.3390/jcdd13040165}
}
EUVIMED